Hideki Makishima

13.7k total citations
134 papers, 4.0k citations indexed

About

Hideki Makishima is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Hideki Makishima has authored 134 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 104 papers in Hematology, 54 papers in Genetics and 43 papers in Molecular Biology. Recurrent topics in Hideki Makishima's work include Acute Myeloid Leukemia Research (94 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (37 papers) and Chronic Myeloid Leukemia Treatments (21 papers). Hideki Makishima is often cited by papers focused on Acute Myeloid Leukemia Research (94 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (37 papers) and Chronic Myeloid Leukemia Treatments (21 papers). Hideki Makishima collaborates with scholars based in United States, Japan and Germany. Hideki Makishima's co-authors include Jaroslaw P. Maciejewski, Mikkael A. Sekeres, Ramón V. Tiu, Christine L. O’Keefe, Hadrian Szpurka, Michael A. McDevitt, Bartlomiej Przychodzen, Valeria Visconte, A. Jankowska and Manuel Afable and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and The Journal of Experimental Medicine.

In The Last Decade

Hideki Makishima

126 papers receiving 4.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hideki Makishima United States 32 2.5k 2.1k 1.4k 658 498 134 4.0k
Valeria Visconte United States 29 1.8k 0.7× 1.4k 0.7× 860 0.6× 756 1.1× 220 0.4× 181 3.2k
R. Coleman Lindsley United States 27 3.0k 1.2× 2.0k 1.0× 1.5k 1.0× 1.8k 2.7× 359 0.7× 76 5.8k
Shigeo Horiike Japan 31 2.1k 0.8× 1.6k 0.8× 933 0.7× 550 0.8× 869 1.7× 165 4.1k
Katharina S. Götze Germany 29 2.7k 1.1× 1.7k 0.8× 1.3k 0.9× 380 0.6× 180 0.4× 130 3.9k
Karl S. Theil United States 27 2.3k 0.9× 1.2k 0.6× 903 0.6× 304 0.5× 290 0.6× 73 3.6k
Hsin‐An Hou Taiwan 34 2.2k 0.9× 1.8k 0.9× 932 0.7× 313 0.5× 212 0.4× 162 3.3k
Carlo Finelli Italy 28 3.2k 1.3× 1.7k 0.8× 1.7k 1.2× 286 0.4× 155 0.3× 108 4.1k
Manja Meggendorfer Germany 27 1.5k 0.6× 854 0.4× 949 0.7× 389 0.6× 261 0.5× 200 2.4k
Elli Papaemmanuil United States 30 1.6k 0.6× 1.6k 0.8× 650 0.5× 257 0.4× 263 0.5× 99 3.0k
Paula Marlton Australia 27 1.2k 0.5× 1.1k 0.5× 789 0.6× 803 1.2× 1.0k 2.1× 137 3.1k

Countries citing papers authored by Hideki Makishima

Since Specialization
Citations

This map shows the geographic impact of Hideki Makishima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hideki Makishima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hideki Makishima more than expected).

Fields of papers citing papers by Hideki Makishima

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hideki Makishima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hideki Makishima. The network helps show where Hideki Makishima may publish in the future.

Co-authorship network of co-authors of Hideki Makishima

This figure shows the co-authorship network connecting the top 25 collaborators of Hideki Makishima. A scholar is included among the top collaborators of Hideki Makishima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hideki Makishima. Hideki Makishima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Suehara, Yasuhito, Yoshiaki Abe, Ryota Matsuoka, et al.. (2024). Genetic profiles and clinical features in subcutaneous panniculitis‐like T‐cell lymphomas. Cancer Science. 115(11). 3788–3794. 1 indexed citations
2.
Makishima, Hideki. (2020). Founder and subclonal mutations in myelodysplastic syndromes and related myeloid neoplasms. Best Practice & Research Clinical Haematology. 33(3). 101189–101189. 2 indexed citations
3.
Campos, Paula de Melo, et al.. (2019). Mutations in Triple-Negative Patients with Myeloproliferative Neoplasms. Blood. 134(Supplement_1). 5395–5395. 3 indexed citations
4.
Molenaar, Remco J., Tomas Radivoyevitch, Yasunobu Nagata, et al.. (2018). IDH1/2 Mutations Sensitize Acute Myeloid Leukemia to PARP Inhibition and This Is Reversed by IDH1/2-Mutant Inhibitors. Clinical Cancer Research. 24(7). 1705–1715. 79 indexed citations
5.
Bartholdy, Boris, Kelly Mitchell, Wendy M. McKimpson, et al.. (2017). A myeloid tumor suppressor role for NOL3. The Journal of Experimental Medicine. 214(3). 753–771. 11 indexed citations
6.
Nagata, Yasunobu, Bartlomiej Przychodzen, Cassandra M. Hirsch, et al.. (2017). Germline SAMD9 and SAMD9L Alterations in Adult Myelodysplastic Syndromes. Blood. 130. 1670–1670. 3 indexed citations
7.
Makishima, Hideki. (2017). Somatic SETBP1 mutations in myeloid neoplasms. International Journal of Hematology. 105(6). 732–742. 18 indexed citations
8.
Yoshizato, Tetsuichi & Hideki Makishima. (2016). Gene mutations in bone marrow failure syndromes.. PubMed. 57(12). 2519–2525. 1 indexed citations
9.
Ruffalo, Matthew, Holleh Husseinzadeh, Hideki Makishima, et al.. (2015). Whole-exome sequencing enhances prognostic classification of myeloid malignancies. Journal of Biomedical Informatics. 58. 104–113. 9 indexed citations
10.
Vishwakarma, Bandana Ajay, Hideki Makishima, Naoko Hosono, et al.. (2015). Runx1 repression by histone deacetylation is critical for Setbp1-induced mouse myeloid leukemia development. Leukemia. 30(1). 200–208. 33 indexed citations
11.
Fang, Jing, Lyndsey Bolanos, Xiaona Liu, et al.. (2014). Myeloid Malignancies with Chromosome 5q Deletions Acquire a Dependency on an Intrachromosomal NF-κB Gene Network. Cell Reports. 8(5). 1328–1338. 49 indexed citations
12.
Sugimoto, Yuka, Mikkael A. Sekeres, Hideki Makishima, et al.. (2012). Cytogenetic and molecular predictors of response in patients with myeloid malignancies without del[5q] treated with lenalidomide. Journal of Hematology & Oncology. 5(1). 4–4. 18 indexed citations
13.
Traina, Fabı́ola, Valeria Visconte, A. Jankowska, et al.. (2012). Single Nucleotide Polymorphism Array Lesions, TET2, DNMT3A, ASXL1 and CBL Mutations Are Present in Systemic Mastocytosis. PLoS ONE. 7(8). e43090–e43090. 86 indexed citations
14.
Makishima, Hideki & Jaroslaw P. Maciejewski. (2011). Pathogenesis and Consequences of Uniparental Disomy in Cancer. Clinical Cancer Research. 17(12). 3913–3923. 73 indexed citations
15.
Makishima, Hideki, Heather Cazzolli, Hadrian Szpurka, et al.. (2009). Mutations of E3 Ubiquitin Ligase Cbl Family Members Constitute a Novel Common Pathogenic Lesion in Myeloid Malignancies. Journal of Clinical Oncology. 27(36). 6109–6116. 150 indexed citations
16.
Makishima, Hideki, Lukasz P. Gondek, Jungwon Huh, et al.. (2009). FISH and SNP-A karyotyping in myelodysplastic syndromes: Improving cytogenetic detection of del(5q), monosomy 7, del(7q), trisomy 8 and del(20q). Leukemia Research. 34(4). 447–453. 53 indexed citations
17.
Dunbar, Andrew, Lukasz P. Gondek, Christine L. O’Keefe, et al.. (2008). 250K Single Nucleotide Polymorphism Array Karyotyping Identifies Acquired Uniparental Disomy and Homozygous Mutations, Including Novel Missense Substitutions of c-Cbl , in Myeloid Malignancies. Cancer Research. 68(24). 10349–10357. 223 indexed citations
18.
Makishima, Hideki, Toshiro Ito, Hideyuki Nakazawa, et al.. (2006). Chemokine system and tissue infiltration in aggressive NK-cell leukemia. Leukemia Research. 31(9). 1237–1245. 26 indexed citations
19.
Choi, Young-Lim, Hideki Makishima, Jun Ohashi, et al.. (2004). DNA microarray analysis of natural killer cell-type lymphoproliferative disease of granular lymphocytes with purified CD3−CD56+ fractions. Leukemia. 18(3). 556–565. 19 indexed citations
20.
Makishima, Hideki, Mitsuaki Isobe, & Hiroshi Imamura. (1998). A case of primary cardiac lymphoma: Utility of serum soluble interleukin-2 receptor for noninvasive diagnosis. International Journal of Cardiology. 65(3). 291–293. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Valeria Visconte Breakdown of academic impact, for papers by R. Coleman Lindsley Breakdown of academic impact, for papers by Shigeo Horiike Breakdown of academic impact, for papers by Katharina S. Götze Breakdown of academic impact, for papers by Karl S. Theil Breakdown of academic impact, for papers by Hsin‐An Hou Breakdown of academic impact, for papers by Carlo Finelli Breakdown of academic impact, for papers by Manja Meggendorfer Breakdown of academic impact, for papers by Elli Papaemmanuil Breakdown of academic impact, for papers by Paula Marlton
Rankless by CCL
2026